Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 33271
[patent_doc_number] => 07790910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Process for the preparation of 7α-alkylated 19-norsteroids'
[patent_app_type] => utility
[patent_app_number] => 11/192071
[patent_app_country] => US
[patent_app_date] => 2005-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12495
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11192071
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/192071 | Process for the preparation of 7α-alkylated 19-norsteroids | Jul 26, 2005 | Issued |
Array
(
[id] => 299901
[patent_doc_number] => 07538100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-26
[patent_title] => '17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations'
[patent_app_type] => utility
[patent_app_number] => 11/188992
[patent_app_country] => US
[patent_app_date] => 2005-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 12116
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/538/07538100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11188992
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/188992 | 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations | Jul 25, 2005 | Issued |
Array
(
[id] => 6931756
[patent_doc_number] => 20050282791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => '18-nor steroids as selectively active estrogens'
[patent_app_type] => utility
[patent_app_number] => 11/184784
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14357
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11184784
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/184784 | 18-nor steroids as selectively active estrogens | Jul 19, 2005 | Abandoned |
Array
(
[id] => 7250453
[patent_doc_number] => 20050272710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration'
[patent_app_type] => utility
[patent_app_number] => 11/183911
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 35895
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183911
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183911 | Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration | Jul 18, 2005 | Issued |
Array
(
[id] => 5794292
[patent_doc_number] => 20060014973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Processes for the preparation of 16beta-alkoxy, 17alpha-hydroxy steroids and steroidal 16beta, 17alpha-diols from 16alpha, 17alpha-epoxy steroids'
[patent_app_type] => utility
[patent_app_number] => 11/182557
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4357
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014973.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182557
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182557 | Processes for the preparation of 16beta-alkoxy, 17alpha-hydroxy steroids and steroidal 16beta, 17alpha-diols from 16alpha, 17alpha-epoxy steroids | Jul 14, 2005 | Abandoned |
Array
(
[id] => 7046149
[patent_doc_number] => 20050250744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Pharmaceutically active compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/182247
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12957
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182247
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182247 | Pharmaceutically active compounds and methods of use thereof | Jul 13, 2005 | Abandoned |
Array
(
[id] => 5101910
[patent_doc_number] => 20070185172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/571894
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4664
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571894 | Organic compounds | Jul 12, 2005 | Abandoned |
Array
(
[id] => 4803601
[patent_doc_number] => 20080015190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Inhibitors of Histone Deacetylase'
[patent_app_type] => utility
[patent_app_number] => 11/629588
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15154
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015190.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629588
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629588 | Inhibitors of Histone Deacetylase | Jul 7, 2005 | Abandoned |
Array
(
[id] => 7070111
[patent_doc_number] => 20050245496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one'
[patent_app_type] => utility
[patent_app_number] => 11/176842
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3132
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245496.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176842 | High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | Jul 6, 2005 | Abandoned |
Array
(
[id] => 5880580
[patent_doc_number] => 20060029662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Immunomodulatory compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/176701
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14059
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176701 | Immunodulatory compositions and methods of use thereof | Jul 6, 2005 | Issued |
Array
(
[id] => 5711116
[patent_doc_number] => 20060052461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'New 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1'
[patent_app_type] => utility
[patent_app_number] => 11/171476
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6624
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11171476
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/171476 | 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 | Jun 30, 2005 | Issued |
Array
(
[id] => 5005530
[patent_doc_number] => 20070203102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Estrogen Receptor Modulators'
[patent_app_type] => utility
[patent_app_number] => 11/629930
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13562
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629930
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629930 | Estrogen Receptor Modulators | Jun 23, 2005 | Abandoned |
Array
(
[id] => 533579
[patent_doc_number] => 07179950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => 'Bromination process'
[patent_app_type] => utility
[patent_app_number] => 11/157104
[patent_app_country] => US
[patent_app_date] => 2005-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6468
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179950.pdf
[firstpage_image] =>[orig_patent_app_number] => 11157104
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/157104 | Bromination process | Jun 19, 2005 | Issued |
Array
(
[id] => 5794046
[patent_doc_number] => 20060014727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Angiogenic compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/158291
[patent_app_country] => US
[patent_app_date] => 2005-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7078
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11158291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/158291 | Angiogenic compounds and uses thereof | Jun 19, 2005 | Abandoned |
Array
(
[id] => 6926505
[patent_doc_number] => 20050239761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Processes for preparation of 9,11-epoxy steroids and intermediates useful therein'
[patent_app_type] => utility
[patent_app_number] => 11/156418
[patent_app_country] => US
[patent_app_date] => 2005-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 46772
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239761.pdf
[firstpage_image] =>[orig_patent_app_number] => 11156418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/156418 | Keto-substituted steroid compounds | Jun 19, 2005 | Issued |
Array
(
[id] => 5739043
[patent_doc_number] => 20060009434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'New 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1'
[patent_app_type] => utility
[patent_app_number] => 11/154947
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10145
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009434.pdf
[firstpage_image] =>[orig_patent_app_number] => 11154947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/154947 | 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 | Jun 16, 2005 | Issued |
Array
(
[id] => 4803584
[patent_doc_number] => 20080015173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Estrogen Receptor Modulators'
[patent_app_type] => utility
[patent_app_number] => 11/628828
[patent_app_country] => US
[patent_app_date] => 2005-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14236
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015173.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628828 | Estrogen Receptor Modulators | Jun 6, 2005 | Abandoned |
Array
(
[id] => 5895437
[patent_doc_number] => 20060003976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds'
[patent_app_type] => utility
[patent_app_number] => 11/145537
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14429
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003976.pdf
[firstpage_image] =>[orig_patent_app_number] => 11145537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/145537 | Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds | Jun 2, 2005 | Abandoned |
Array
(
[id] => 884055
[patent_doc_number] => RE040183
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2008-03-25
[patent_title] => '7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines'
[patent_app_type] => reissue
[patent_app_number] => 11/145508
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60143
[patent_no_of_claims] => 103
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/040/RE040183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11145508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/145508 | 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines | Jun 2, 2005 | Issued |
Array
(
[id] => 7020454
[patent_doc_number] => 20050222473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Bromination process'
[patent_app_type] => utility
[patent_app_number] => 11/142980
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6354
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222473.pdf
[firstpage_image] =>[orig_patent_app_number] => 11142980
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/142980 | Bromination process | Jun 1, 2005 | Issued |